Houston, TX, United States of America

Jie He

This inventor holds 1 USPTO granted patent. Top assignee: University of Houston System. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie He. Retrieved from https://idiyas.com/inventor/jie-he-bka66ner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jie He in Liposomal Formulations

Introduction

Jie He is an accomplished inventor based in Houston, Texas. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liposomal drug delivery systems.

Latest Patents

Jie He holds a patent for "Liposomal formulations of polymyxin and uses thereof." This invention provides novel liposomal formulations of polymyxin B, which are useful for treating bacterial infections. The formulation consists of a lipid component that forms vesicles with a minimum size of at least 500 nm, encapsulating polymyxin B. This innovative drug delivery system enhances the efficacy of bacterial infection treatments by improving the bioavailability and distribution of polymyxin B within the subject.

Career Highlights

Jie He is affiliated with the University of Houston System, where he continues to advance research in pharmaceutical sciences. His work focuses on improving drug delivery methods to enhance treatment outcomes for patients suffering from bacterial infections.

Collaborations

Some of Jie He's notable coworkers include Vincent Tam and Diana Shu-Lian Chow. Their collaborative efforts contribute to the ongoing research and development in the field of liposomal formulations.

Conclusion

Jie He's innovative work in liposomal formulations represents a significant advancement in the treatment of bacterial infections. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…